CHICAGO –- Chemical manufacturer DuPont Co. is considering divesting some of its businesses, according to company CEO Charles Holliday.
Holliday said that the company may have to divest some businesses to focus on its fastest-growing units, such as those developing biotechnology-based products. DuPont said in December that it planned to sell its $1.49 billion drug business.